Literature DB >> 7793886

Bioluminescence method to evaluate antimicrobial agents against Mycobacterium avium.

R C Cooksey1, G P Morlock, M Beggs, J T Crawford.   

Abstract

Plasmid pLUC10, carrying the firefly luciferase gene, was transformed by electroporation into Mycobacterium avium A5. Bioluminescence production by strain A5(pLUC10), as measured in a microdilution plate luminometer, was approximately 1 relative light unit per 2 x 10(6) viable bacilli, whereas it was 0.0005 relative light unit for an equal number of parental cells. The susceptibility of strain A5(pLUC10) to eight concentrations of each of eight antimicrobial agents was evaluated by the luciferase microplate assay in parallel with a conventional broth macrodilution method with antimicrobial agents. Decreases in bioluminescence to levels that were < or = 10% of those of drug-free controls were observed in microplate wells containing inhibitory concentrations of drugs in as few as 3 days. The close correlation of these inhibitory concentrations with the MICs determined by a conventional broth macrodilution method suggests that the luciferase microplate method may offer a convenient and reliable means of evaluating the in vitro activities of antimicrobial agents against the M. avium complex.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7793886      PMCID: PMC162618          DOI: 10.1128/AAC.39.3.754

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

Review 1.  Mycobacterium avium complex infection in the acquired immunodeficiency syndrome.

Authors:  C R Horsburgh
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

2.  A rapid method for screening antimicrobial agents for activities against a strain of Mycobacterium tuberculosis expressing firefly luciferase.

Authors:  R C Cooksey; J T Crawford; W R Jacobs; T M Shinnick
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

3.  Rapid procedure for detection and isolation of large and small plasmids.

Authors:  C I Kado; S T Liu
Journal:  J Bacteriol       Date:  1981-03       Impact factor: 3.490

4.  Plasmid analysis of Mycobacterium avium-intracellulare (MAI) isolated in the United Kingdom from patients with and without AIDS.

Authors:  T J Hellyer; I N Brown; J W Dale; C S Easmon
Journal:  J Med Microbiol       Date:  1991-04       Impact factor: 2.472

5.  Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex.

Authors:  H Masur
Journal:  N Engl J Med       Date:  1993-09-16       Impact factor: 91.245

Review 6.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

7.  Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients.

Authors:  S D Nightingale; L T Byrd; P M Southern; J D Jockusch; S X Cal; B A Wynne
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

  7 in total
  11 in total

1.  Alternative luciferase for monitoring bacterial cells under adverse conditions.

Authors:  Siouxsie Wiles; Kathryn Ferguson; Martha Stefanidou; Douglas B Young; Brian D Robertson
Journal:  Appl Environ Microbiol       Date:  2005-07       Impact factor: 4.792

2.  Development of a firefly luciferase-based assay for determining antimicrobial susceptibility of Mycobacterium avium subsp. paratuberculosis.

Authors:  S L Williams; N B Harris; R G Barletta
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

3.  Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery.

Authors:  T M Arain; A E Resconi; M J Hickey; C K Stover
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

4.  Rapid screening of natural products for antimycobacterial activity by using luciferase-expressing strains of Mycobacterium bovis BCG and Mycobacterium intracellulare.

Authors:  R M Shawar; D J Humble; J M Van Dalfsen; C K Stover; M J Hickey; S Steele; L A Mitscher; W Baker
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

5.  Green fluorescent protein reporter microplate assay for high-throughput screening of compounds against Mycobacterium tuberculosis.

Authors:  L A Collins; M N Torrero; S G Franzblau
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

6.  Optimisation of bioluminescent reporters for use with mycobacteria.

Authors:  Nuria Andreu; Andrea Zelmer; Taryn Fletcher; Paul T Elkington; Theresa H Ward; Jorge Ripoll; Tanya Parish; Gregory J Bancroft; Ulrich Schaible; Brian D Robertson; Siouxsie Wiles
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

7.  Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice.

Authors:  M J Hickey; T M Arain; R M Shawar; D J Humble; M H Langhorne; J N Morgenroth; C K Stover
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

8.  Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence.

Authors:  Nuria Andreu; Taryn Fletcher; Nitya Krishnan; Siouxsie Wiles; Brian D Robertson
Journal:  J Antimicrob Chemother       Date:  2011-11-17       Impact factor: 5.790

9.  A high-throughput cidality screen for Mycobacterium tuberculosis.

Authors:  Parvinder Kaur; Anirban Ghosh; Ramya Vadageri Krishnamurthy; Deepa Gagwani Bhattacharjee; Vijayashree Achar; Santanu Datta; Shridhar Narayanan; Anand Anbarasu; Sudha Ramaiah
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

10.  Reporter-Based Assays for High-Throughput Drug Screening against Mycobacterium abscessus.

Authors:  Rashmi Gupta; Mandy Netherton; Thomas F Byrd; Kyle H Rohde
Journal:  Front Microbiol       Date:  2017-11-10       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.